Juvenescence Ltd - Feb 7, 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Stock symbol
AGE
Transactions as of
Feb 7, 2023
Transactions value $
$0
Form type
4
Date filed
2/8/2023, 03:00 PM
Previous filing
Dec 19, 2022
Next filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +340K $0.00 340K Feb 7, 2023 Common Stock 340K $0.74 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under a Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization